Sökning: onr:"swepub:oai:DiVA.org:uu-342526" >
Time-based measures...
-
Bellavia, Andrea
(författare)
Time-based measures of treatment effect : reassessment of ticagrelor and clopidogrel from the PLATO trial
- Artikel/kapitelEngelska2017
Förlag, utgivningsår, omfång ...
-
2017-06-01
-
BMJ,2017
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-342526
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-342526URI
-
https://doi.org/10.1136/openhrt-2016-000557DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:228761675URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
OBJECTIVE: Treatment effects to binary endpoints using time-to-event data in randomised controlled trials are typically summarised by reporting HRs derived with Cox proportional hazard models. Alternative and complementary methods include summarising the between-treatment differences on the metric time scale, quantifying the effect as delay of the event (DoE). The aim of this study was to reassess data from the PLATO study expressing the effects as the time by which the main outcomes are delayed or hastened due to treatment.METHODS: PLATO was a randomised controlled double-blind multicentre study (n=18,624), conducted between 2006 and 2008, which demonstrated superiority of the antiplatelet treatment ticagrelor over clopidogrel in reducing risk of several cardiovascular events. In the present study, four of the main PLATO outcomes were reassessed by calculating the time by which an event may be delayed due to the treatment.RESULTS: The effects of ticagrelor, as compared with clopidogrel, consisted of a substantial delay of the evaluated outcomes, ranging from 83 to 98 days over 400-day follow-up. The Delay of Events Curves showed that the effects progressively increased over time, and the significant findings were concordant with those presented in the original PLATO study.CONCLUSIONS: This study confirmed evidence of a beneficial effect of ticagrelor over clopidogrel, and provided the magnitude of such effects in terms of delayed event time. Investigating time-to-event data with a percentile approach allows presenting treatment effects from randomised controlled studies as absolute measures of the time by which an event may be delayed due to the treatment.TRIAL REGISTRATION NUMBER: PLATO (www.clinicaltrials.gov; NCT00391872); Results.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall
(författare)
-
Orsini, NicolaKarolinska Institutet
(författare)
-
James, Stefan K,1964-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)stjam367
(författare)
-
Cannon, Christopher P
(författare)
-
Himmelmann, Anders
(författare)
-
Sundström, JohanUppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)johasund
(författare)
-
Renlund, Henrik,1979-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)henre358
(författare)
-
Lytsy, Per,1968-Uppsala universitet,Socialmedicinsk epidemiologi(Swepub:uu)pelut933
(författare)
-
Uppsala universitetKardiologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Open heart: BMJ4:22053-3624
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bellavia, Andrea
-
Wallentin, Lars, ...
-
Orsini, Nicola
-
James, Stefan K, ...
-
Cannon, Christop ...
-
Himmelmann, Ande ...
-
visa fler...
-
Sundström, Johan
-
Renlund, Henrik, ...
-
Lytsy, Per, 1968 ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Open heart
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet